Clinical trial · Observational
Automated Device for Asthma Monitoring and Management in Monitoring Adults With Lung Cancer Undergoing Radiation Therapy
A Pilot Study Investigating the Feasibility of ADAMM (Automated Device for Asthma Monitoring and Management) in Combination With Electronic Patient-Reported Outcomes in Adult Patients With Lung Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This pilot early phase I trial studies the Automated Device for Asthma Monitoring and Management in monitoring adult patients with lung cancer who are undergoing radiation therapy. The Automated Device for Asthma Monitoring and Management may provide useful information to doctors to help monitor adult patients with lung cancer and diagnose certain conditions earlier than traditional means.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Carcinoma | Lung Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Monitoring Device | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Device Feasibility (ADAMM)
- description
- Patients wear the Automated Device for Asthma Monitoring and Management (ADAMM) from the time of computed tomography (CT) simulation for radiation therapy (RT) planning throughout the entire RT course and for 4 weeks post-RT
- interventionNames
- Device: Monitoring Device
Primary outcomes (2)
- measure
- Percentage of hours per day that patients wear the Automated Device for Asthma Monitoring and Management device
- timeFrame
- Up to 4 weeks post-radiation therapy
- description
- The compliance rate along with a one-sided exact 95% confidence interval will be estimated.
- measure
- Percentage of days per study period that patients wear the Automated Device for Asthma Monitoring and Management device
- timeFrame
- Up to 4 weeks post-radiation therapy
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients are capable of giving informed consent * Patients are eligible to be treated with RT and plan to start treatment * Patients have either metastatic or non-metastatic lung cancer as defined in history and physical * Patients must be able to read or speak English * Women of reproductive potential should have a negative serum or urine pregnancy test within one week prior to radiation planning CT scan Exclusion Criteria: * Patients who cannot read or speak English * Patients who are not candidates for RT treatment * Women of childbearing potential who are pregnant or breastfeeding
References
Publications (0)
Data not yet available